​

Teladoc Health (TDOC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TDOC Stock Forecast

Teladoc Health (TDOC) stock forecast, based on 40 Wall Street analysts, predicts a 12-month average price target of $10.00, with a high of $10.00 and a low of $10.00. This represents a 32.98% increase from the last price of $7.52.

$5 $9 $13 $17 $21 $25 High: $10 Avg: $10 Low: $10 Last Closed Price: $7.52

TDOC Stock Rating

Teladoc Health stock's rating consensus is Hold, based on 40 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (35.00%), 26 Hold (65.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 40 0 26 14 Strong Sell Sell Hold Buy Strong Buy

TDOC Price Target Upside V Benchmarks

TypeNameUpside
StockTeladoc Health32.98%
SectorHealthcare Stocks 19.91%
IndustryHealthcare Information Services Stocks 11.10%

Price Target Trends

1M3M12M
# Anlaysts114
Avg Price Target$10.00$10.00$10.75
Last Closing Price$7.52$7.52$7.52
Upside/Downside32.98%32.98%42.95%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 251420--25
Jul, 252319--24
Jun, 252319--24
May, 252319--24
Apr, 252319--24
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 30, 2025Raymond James$10.00$7.4035.14%32.98%
Dec 04, 2024Jessica TassanPiper Sandler$13.00$11.0118.07%72.87%
Oct 31, 2024Daniel GrosslightCitigroup$11.00$8.8624.15%46.28%
Oct 30, 2024Elizabeth AndersonEvercore ISI$9.00$8.861.58%19.68%
Aug 06, 2024Jessica TassanPiper Sandler$10.00$7.6031.58%32.98%
Jun 11, 2024Steve ValiquetteBarclays$20.00$10.4990.66%165.96%
May 31, 2024Glen SantangeloJefferies$10.00$11.29-11.43%32.98%
May 20, 2024Glen SantangeloJefferies$14.00$12.3912.99%86.17%
Apr 05, 2024George HillDeutsche Bank$18.00$14.6522.87%139.36%
Apr 12, 2023Jeff GarroStephens$25.00$25.86-3.33%232.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 30, 2025Cantor FitzgeraldOverweightOverweighthold
Dec 04, 2024Piper SandlerOverweightOverweighthold
Oct 31, 2024Cowen & Co.HoldHoldhold
Oct 31, 2024BarclaysOverweightOverweighthold
Oct 31, 2024CitigroupNeutralNeutralhold
Oct 09, 2024RBC CapitalOutperformOutperformhold
Oct 08, 2024RBC CapitalBuyBuyhold
Oct 08, 2024Evercore ISIOutperformOutperformhold
Sep 17, 2024RBC CapitalBuyBuyhold
Sep 17, 2024JefferiesBuyBuyhold

Financial Forecast

EPS Forecast

$-85 $-67 $-49 $-31 $-13 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.36$-2.73$-84.60$-1.36$-5.87----
Avg Forecast$-1.37$-3.25$-61.26$-1.38$-5.82$-0.89$-0.80$-0.63$-0.03
High Forecast$-1.28$-3.04$-58.91$-0.99$-5.64$-0.50$-0.08$0.47$-0.02
Low Forecast$-1.44$-3.42$-63.04$-1.45$-5.94$-1.23$-1.20$-1.11$-0.03
Surprise %291.24%-16.00%38.10%-1.45%0.86%----

Revenue Forecast

$1B $1B $2B $2B $3B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.09B$2.03B$2.41B$2.60B$2.57B----
Avg Forecast$1.09B$2.03B$2.40B$2.61B$2.57B$2.55B$2.59B$2.66B$2.75B
High Forecast$1.13B$2.11B$2.46B$2.62B$2.60B$2.61B$2.59B$2.66B$2.82B
Low Forecast$1.03B$1.92B$2.33B$2.51B$2.55B$2.41B$2.58B$2.66B$2.64B
Surprise %0.41%0.35%0.18%-0.39%0.04%----

Net Income Forecast

$-550B $-430B $-310B $-190B $-70B $50B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-485.14M$-428.79M$-13.66B$-220.37M$-1.00B----
Avg Forecast$-3.89B$-385.89M$-434.22B$-220.37M$-953.23M$-156.71M$-148.59M$-92.16M$-4.11M
High Forecast$-3.11B$-308.71M$-347.37B$-176.29M$-928.45M$-81.96M$-12.97M$77.75M$-3.90M
Low Forecast$-4.67B$-463.07M$-521.06B$-264.44M$-978.01M$-201.87M$-197.67M$-182.81M$-4.24M
Surprise %-87.53%11.12%-96.85%-5.04%----

TDOC Forecast FAQ

Is Teladoc Health stock a buy?

Teladoc Health stock has a consensus rating of Hold, based on 40 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 26 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Teladoc Health is a neutral investment for most analysts.

What is Teladoc Health's price target?

Teladoc Health's price target, set by 40 Wall Street analysts, averages $10 over the next 12 months. The price target range spans from $10 at the low end to $10 at the high end, suggesting a potential 32.98% change from the previous closing price of $7.52.

How does Teladoc Health stock forecast compare to its benchmarks?

Teladoc Health's stock forecast shows a 32.98% upside, outperforming the average forecast for the healthcare stocks sector (19.91%) and outperforming the healthcare information services stocks industry (11.10%).

What is the breakdown of analyst ratings for Teladoc Health over the past three months?

  • August 2025: 4.00% Strong Buy, 16.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 8.33% Strong Buy, 12.50% Buy, 79.17% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 8.33% Strong Buy, 12.50% Buy, 79.17% Hold, 0% Sell, 0% Strong Sell.

What is Teladoc Health’s EPS forecast?

Teladoc Health's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.89, marking a -84.84% decrease from the reported $-5.87 in 2024. Estimates for the following years are $-0.8 in 2026, $-0.63 in 2027, and $-0.03 in 2028.

What is Teladoc Health’s revenue forecast?

Teladoc Health's average annual revenue forecast for its fiscal year ending in December 2025 is $2.55B, reflecting a -0.94% decrease from the reported $2.57B in 2024. The forecast for 2026 is $2.59B, followed by $2.66B for 2027, and $2.75B for 2028.

What is Teladoc Health’s net income forecast?

Teladoc Health's net income forecast for the fiscal year ending in December 2025 stands at $-157M, representing a -84.35% decrease from the reported $-1.001B in 2024. Projections indicate $-149M in 2026, $-92.161M in 2027, and $-4.114M in 2028.